EXOZYMES INC. Cash Equivalents, at Carrying Value
EXOZYMES INC. (EXOZ) had Cash Equivalents, at Carrying Value of $6.99 million as of 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2025-08-12
- 2025-06-30: Cash Equivalents, at Carrying Value $6.99M.
- 2025-03-31: Cash Equivalents, at Carrying Value $8.16M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-06-30 | $6.99M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $8.16M 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |